The biotechnology company, ArborGen, conducts research and development on the genomic structures of forest trees to create hybrid seedlings with desirable traits like freeze tolerance. They operate in the USA, Australia, and Brazil, conducting field trials on over a million trees. ArborGen offers a range of timber trees, tailored to different geographies. With a focus on helping landowners make the best reforestation decisions, ArborGen provides high-performing seedlings and exceptional service. Their advanced genetic technologies result in trees that offer outstanding silvicultural performance for forest landowners.